VUOLO, LUISA
VUOLO, LUISA
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis.
2017 M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L.
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience
2012 Mancardi, G.L.; Sormani, M.P.; Di Gioia, M.; Vuolo, L.; Gualandi, F.; Amato, M.P.; Capello, E.; Currò, D.; Uccelli, A.; Bertolotto, A.; Gasperini, C.; Lugaresi, A.; Merelli, E.; Meucci, G.; Motti, L.; Tola, M.R.; Scarpini, E.; Repice, A.M.; Massacesi, L.; Saccardi, R.
Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial
2012 Mancardi, GL; Sormani, MP; Gualandi, F; Saiz, A; Carreras, E; Merelli, E; Donelli, A; Lugaresi, A; Di Bartolomeo, P; Rambaldi, A; Rottoli, M; Amato, MP; Massacesi, L; Di Gioia, M; Vuolo, L; Curro, D; Roccatagliata, L; Capello, E; Uccelli, A; Iacopino, P; Aguglia, U; Filippi, M; Saccardi, R
Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume
2015 Bandieri, L; Vuolo, L; Repice, AM; Grammatico, M; Mechi, C; Massacesi, L
Central vein sign differentiates MS from CNS inflammatory vasculopathies.
2018 Maggi, P; Absinta, M; M, Grammatico; Vuolo, L; Emmi, G; Carlucci, G; Spagni, G; Barilaro, A; Repice, Am; Emmi, L; Prisco, D; Martinelli, V; Scotti, R; Sadeghi, N; Perrotta, G; Sati, P; Dachy, B; Reich, Ds; Filippi, M; Massacesi, L.
Comparison of azathioprine and of beta interferon efficacy on measures of brain damage evaluated by MRI in relapsing-remitting multiple sclerosis
2016 Massacesi, L; Grammatico, M; Vuolo, L; Barilaro, A; Benedetti, MD; La Mantia, L; Milanese, C; Repice, AM; Solari, A; Tedeschi, G; Filippini, G
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis.
2017 M., Grammatico; Dallagiacoma, S.; Lorenzoni, L.; Carlucci, G.; Repice, A. M.; Mechi, C.; Magnani, E.; Vuolo, L.; Fainardi, E.; Massacesi, L.
Efficiency of FLAIR* at 1.5T, 3T, and 7T for detecting perivenular lesions in multiple sclerosis (MS)
2015 Vuolo, L; Dewey, B; Sati, P; Massacesi, L; Reich, DS
Imaging perivenular distribution can differentiate MS from CNS vasculitis.
2015 Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A. M.; Mechi, C.; Grammatico Di Tullio, M.; Silvestri, E.; Barilaro, A.; Prisco, D.; Emmi, L.; Massacesi, L.
Leptomeningeal and parenchymal MS lesions through MRI at different magnetic fields.
2015 Vuolo L
Leptomeningeal enhancement analysis in diagnostic clinical setting
2015 Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Forci, B; Massacesi, L
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases.
2016 Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A.; Magnani, E.; Spagni, G.; Prisco, D.; Silvestri, E.; Barilaro, A.; Sati, P.; Reich, D.; Massacesi, L.
Preliminary results of ASTIMS, a prospective randomised Phase II EBMT trial on autologous HSCT in poor prognosis Multiple Sclerosis
2012 Mancardi, GL; Sormani, MP; Gualandi, F; Saiz, A; Carreras, E; Merelli, E; Donelli, A; Lugaresi, A; Di Bartolomeo, P; Rottoli, M; Rambaldi, A; Amato, MP; Massacesi, L; Vuolo, L; Curro, D; Roccatagliata, L; Filippi, M; Russo, C; Iacopino, P; Saccardi, R
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series
2021 Fonderico, Mattia; Biagioli, Tiziana; Lanzilao, Luisa; Bellinvia, Angelo; Fratangelo, Roberto; Pastò, Luisa; Prestipino, Elio; Razzolini, Lorenzo; Tudisco, Laura; Ginestroni, Andrea; Vuolo, Luisa; Fainardi, Enrico; Ballerini, Clara; Portaccio, Emilio; Amato, Maria Pia
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies.
2015 Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A. M.; Mechi, C.; M., Grammatico; Prisco, D.; Silvestri, E.; Barilaro, A.; Emmi, L.; Massacesi, L.
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination
2018 Grammatico, M; Carlucci, G; Dallagiacoma, S; Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. | 2017 | M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L. | |
| Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience | 2012 | Mancardi, G.L.; Sormani, M.P.; Di Gioia, M.; Vuolo, L.; Gualandi, F.; Amato, M.P.; Capello, E.; Currò, D.; Uccelli, A.; Bertolotto, A.; Gasperini, C.; Lugaresi, A.; Merelli, E.; Meucci, G.; Motti, L.; Tola, M.R.; Scarpini, E.; Repice, A.M.; Massacesi, L.; Saccardi, R. | |
| Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial | 2012 | Mancardi, GL; Sormani, MP; Gualandi, F; Saiz, A; Carreras, E; Merelli, E; Donelli, A; Lugaresi, A; Di Bartolomeo, P; Rambaldi, A; Rottoli, M; Amato, MP; Massacesi, L; Di Gioia, M; Vuolo, L; Curro, D; Roccatagliata, L; Capello, E; Uccelli, A; Iacopino, P; Aguglia, U; Filippi, M; Saccardi, R | |
| Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume | 2015 | Bandieri, L; Vuolo, L; Repice, AM; Grammatico, M; Mechi, C; Massacesi, L | |
| Central vein sign differentiates MS from CNS inflammatory vasculopathies. | 2018 | Maggi, P; Absinta, M; M, Grammatico; Vuolo, L; Emmi, G; Carlucci, G; Spagni, G; Barilaro, A; Repice, Am; Emmi, L; Prisco, D; Martinelli, V; Scotti, R; Sadeghi, N; Perrotta, G; Sati, P; Dachy, B; Reich, Ds; Filippi, M; Massacesi, L. | |
| Comparison of azathioprine and of beta interferon efficacy on measures of brain damage evaluated by MRI in relapsing-remitting multiple sclerosis | 2016 | Massacesi, L; Grammatico, M; Vuolo, L; Barilaro, A; Benedetti, MD; La Mantia, L; Milanese, C; Repice, AM; Solari, A; Tedeschi, G; Filippini, G | |
| Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis. | 2017 | M., Grammatico; Dallagiacoma, S.; Lorenzoni, L.; Carlucci, G.; Repice, A. M.; Mechi, C.; Magnani, E.; Vuolo, L.; Fainardi, E.; Massacesi, L. | |
| Efficiency of FLAIR* at 1.5T, 3T, and 7T for detecting perivenular lesions in multiple sclerosis (MS) | 2015 | Vuolo, L; Dewey, B; Sati, P; Massacesi, L; Reich, DS | |
| Imaging perivenular distribution can differentiate MS from CNS vasculitis. | 2015 | Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A. M.; Mechi, C.; Grammatico Di Tullio, M.; Silvestri, E.; Barilaro, A.; Prisco, D.; Emmi, L.; Massacesi, L. | |
| Leptomeningeal and parenchymal MS lesions through MRI at different magnetic fields. | 2015 | Vuolo L | |
| Leptomeningeal enhancement analysis in diagnostic clinical setting | 2015 | Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Forci, B; Massacesi, L | |
| MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. | 2016 | Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A.; Magnani, E.; Spagni, G.; Prisco, D.; Silvestri, E.; Barilaro, A.; Sati, P.; Reich, D.; Massacesi, L. | |
| Preliminary results of ASTIMS, a prospective randomised Phase II EBMT trial on autologous HSCT in poor prognosis Multiple Sclerosis | 2012 | Mancardi, GL; Sormani, MP; Gualandi, F; Saiz, A; Carreras, E; Merelli, E; Donelli, A; Lugaresi, A; Di Bartolomeo, P; Rottoli, M; Rambaldi, A; Amato, MP; Massacesi, L; Vuolo, L; Curro, D; Roccatagliata, L; Filippi, M; Russo, C; Iacopino, P; Saccardi, R | |
| Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series | 2021 | Fonderico, Mattia; Biagioli, Tiziana; Lanzilao, Luisa; Bellinvia, Angelo; Fratangelo, Roberto; Pastò, Luisa; Prestipino, Elio; Razzolini, Lorenzo; Tudisco, Laura; Ginestroni, Andrea; Vuolo, Luisa; Fainardi, Enrico; Ballerini, Clara; Portaccio, Emilio; Amato, Maria Pia | |
| Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. | 2015 | Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A. M.; Mechi, C.; M., Grammatico; Prisco, D.; Silvestri, E.; Barilaro, A.; Emmi, L.; Massacesi, L. | |
| The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination | 2018 | Grammatico, M; Carlucci, G; Dallagiacoma, S; Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L |